Search Share Prices
AZN Headlines - AstraZeneca share price: Pharmco starts CEO succession planning
AstraZeneca (LON:AZN) has begun succession planning for its chief executive Pascal Soriot, following shareholder pressure, The Sunday times has revealed. The news comes after the Anglo-Swedish ...
JPMorgan Chase & Co. Reiterates “GBX 6,900” Price Target for AstraZeneca (AZN)
JPMorgan Chase & Co. set a GBX 6,900 ($90.16) target price on AstraZeneca (LON:AZN) in a report released on Friday morning. The firm currently has a buy rating on the biopharmaceutical company’s stock ...
Is AstraZeneca PLC (LON:AZN) Excessively Paying Its CEO?
Pascal Soriot became the CEO of AstraZeneca PLC (LON:AZN) in 2012. First, this article will compare CEO compensation with compensation at other large companies. Next, we’ll consider growth that ...
AstraZeneca heads south after disappointing MYSTIC trial results
Shares in AstraZeneca (LON:AZN) have lost ground in London in today’s session, as the company posted disappointing results from its key MYSTIC study. The setback comes after the highly-awaited ...
AstraZeneca in cancer drug setback
AstraZeneca PLC (LON:AZN) said its drug Imfinzi was no better than chemotherapy in treating patients with non-small cell lung cancer which has spread to other organs. The medication was used on its ow...